The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion

• Main Authors: Justine M. Z. van Tongeren (Author), S. Froukje Harkes-Idzinga (Author), Heleen van der Sijs (Author), Roya Atiqi (Author), Bart J. F. van den Bemt (Author), L. Willem Draijer (Author), Deline Hiel (Author), Adrian Kerremans (Author), Bart Kremers (Author), Marc de Leeuw (Author), Marleen V. Olthoff (Author), T. Kim-Loan Pham (Author), Ricky Valentijn-Robertz (Author), Kayan Tsoi (Author), Iris Wichers (Author), Maaike de Wit (Author), Sander D. Borgsteede (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundDrug-disease interactions negatively affect the benefit/risk ratio of drugs for specific populations. In these conditions drugs should be avoided, adjusted, or accompanied by extra monitoring. The motivation for many drug-disease interactions in the Summary of Product Characteristics (SmPC...